Patented biomarker for cardiac injury. 

Patented biomarker for cardiac injury. 

ESC365-Roche Satellite Webinar: Exploring the power of novel and established cardiac biomarkers – cMyC as a new potential serum biomarker of AMI

Understand the diagnostic performance of cardiac myosin-binding protein C for the early diagnosis of myocardial infarction in combination with high-sensitivity cardiac troponin and how dual and single biomarker strategies compare.

“It is the first time a new biomarker showed a higher diagnostic performance than the state-of-the-art for the early diagnosis of myocardial infarction.”